We are live on ! Find out more
PETX

Aratana Therapeutics, Inc.
PETX

Delisted

PETX was delisted on the 17th of July, 2019.

Back to rankings

Fund managers haven’t disclosed any holdings of PETX yet.

PETX Hedge Fund Activity: Q4 2019 in Review

0 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q4 2019, worth a combined $0 — down 100% from $267K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PETX and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Davenport & Co, exiting entirely with an estimated $262K sold.

  • 0 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q4 2019, down from 2 in Q3 2019.
  • Funds reported $0 of Aratana Therapeutics, Inc. stock for Q4 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Aratana Therapeutics, Inc. positions in Q4 2019 and 2 closed out, a net change of -2 holders.
  • The largest Aratana Therapeutics, Inc. seller in Q4 2019 was Davenport & Co, an estimated $262K sold.

Based on aggregated 13F filings for Q4 2019.